Zearalenone is a mycotoxin produced by Fusarium fungi, commonly contaminating cereal crops like corn, wheat, barley, sorghum, and oats, especially under conditions of high humidity and low temperatures.
Mycotoxins, produced by molds, can cause acute and chronic symptoms across multiple body systems.
Zearalenone exhibits potent estrogenic activity, resembling the hormone estrogen, and competes with 17β-estradiol for estrogen receptors.
This property allows Zearalenoneto act as an endocrine disruptor, leading to various health issues in animals and humans, including reproductive disorders and potential carcinogenic effects.
Zearalenone contamination in the food chain poses significant health risks, affecting a wide range of food products and leading to hyperestrogenism in animals, particularly swine and cattle.
In humans, Zearalenoneexposure is associated with reproductive diseases and other health concerns, highlighting the importance of addressing and mitigating its presence in food and feed.
Zearalenone is a mycotoxin produced by Fusarium fungi species that frequently contaminates cereal crops [4., 7.].
It commonly contaminates corn, wheat, barley, sorghum, oats, and other crops, particularly under conditions of high humidity and low temperatures (10-15°C) [1.].
It exhibits potent estrogenic activity, which can be enhanced by certain metabolites [7.].
Zearalenone's structure resembles estrogen, allowing it to compete with 17β-estradiol for estrogen receptors [4.]. This endocrine-disrupting property can lead to various health issues in animals and humans, including reproductive disorders and potential carcinogenic effects [4., 7.].
Zearalenone's presence in the food chain poses significant health risks. It can accumulate in living organisms and contaminate various trophic levels, from crops to human consumers [4.].
Zearalenoneis not removed during processing and affects various food products including cereals, meat, milk, wine, beer, dried fruits, and spices [9.].
In animals, Zearalenone is linked to hyperestrogenism, with swine being the most sensitive to its effects [1.].
Effects in swine include vulva swelling, vaginal prolapse, uterine enlargement, mammary gland enlargement, infertility, embryonic death, and reduced litter size [1., 16.].
In cattle, high zearalenone levels can cause infertility, mammary gland enlargement, reduced milk production, and vaginal issues, especially in immature dairy heifers [1.]. Poultry are less susceptible, but large concentrations can lead to vent enlargement and secondary sex characteristics [1.].
Some countries have established regulatory limits for Zearalenone in certain commodities [19.].
Zearalenone (ZEA), a mycotoxin produced by Fusarium fungi, is a xenoestrogen that can disrupt hormonal balance in humans [3.].
It structurally resembles estrogen, allowing it to bind to estrogen receptors and exert estrogen-like effects [17., 18.].
As a xenoestrogen Zearalenone mimics natural estrogens, binding to estrogen receptors and disrupting hormonal balance, potentially leading to reproductive diseases such as prostate, ovarian, cervical, and breast cancers [9.].
Studies have shown that Zearalenone exposure can result in conditions such as precocious puberty in young girls and hyperestrogenic syndromes in humans, highlighting its significant impact as an endocrine disruptor [17.].
The structure of Zearalenone resembles natural estrogen, allowing it to bind to estrogen receptors and exhibit estrogenic activity [2.].
This can lead to endocrine disruption and promote the proliferation of estrogen receptor-positive cell lines [2.].
Zearalenone also causes oxidative damage, endoplasmic reticulum stress, apoptosis, and systemic toxic effects, including reproductive toxicity, hepatotoxicity, and immunotoxicity [2., 18.].
Zearalenone's carcinogenic potential is linked to its ability to stimulate cell proliferation at low doses and induce cell death at high doses through multiple mechanisms, including oxidative stress and DNA damage [2., 18.].
Zearalenone exhibits estrogenic activity, which is enhanced in certain reductive metabolites, potentially disrupting the endocrine system in humans and animals [3., 7.].
Zearalenone is efficiently metabolized in the human intestines, producing α-zearalenol and β-zearalenol as primary metabolites [14.].
The intestinal metabolism of Zearalenone produces α-zearalenol as the predominant metabolite, which has the strongest estrogenic activity and is preferentially transferred to the basal side of intestinal cells [14.].
In contrast, other metabolites remain primarily in the intestinal lumen [14.]
Once inside the body, Zearalenone and its metabolites, both of which have estrogenic activity, can affect the synthesis and secretion of sex hormones, including testosterone, estradiol, and progesterone, by influencing the production of FSH and LH in the pituitary gland [17.].
It can also reduce Leydig and granulosa cells through oxidative stress and cell apoptosis [17.].
Mycotoxins, produced by molds, can cause acute and chronic symptoms across multiple body systems [11.].
As a mycotoxin and an endocrine disrupting chemical (EDC), zearalenone buildup in the human body can manifest in a variety of ways. Some of the more commonly seen symptoms include:
Zeranol (7α-zearalanol) is a semi-synthetic estrogenic veterinary drug with growth-promoting properties, banned in the European Union since 1981 and recognized as a prohibited substance in sports due to its anabolic effects.
The challenge in differentiating between illegal use of zeranol and unintended contamination from the mycotoxin zearalenone, which naturally converts to zeranol, poses a significant issue.
Zeranol is banned in animal husbandry and sports. However, it can be metabolically derived from the mycotoxin zearalenone found in contaminated food.
Differentiating between deliberate doping and contamination is crucial. Routine doping controls monitor zeranol, its metabolites, and related mycotoxins using validated gas chromatography-mass spectrometry methods.
An administration study revealed only ultra-trace amounts of zearalenone metabolites after zeranol intake, suggesting contamination as the cause in doping cases rather than direct misuse.
Laboratory companies often utilize urine samples to test for the presence of mycotoxins such as zearalenone.
Enzyme-linked immunosorbent assay (ELISA) is a widely used method for detecting zearalenone. These methods typically involve the production of monoclonal antibodies against zearalenone.
ELISA methods have shown good specificity for Zearalenone, with some cross-reactivity observed for structurally similar compounds [5., 15.].
Samples can be collected from the comfort of home. It is essential to consult with the ordering provider prior to sample collection, as the provider may recommend the use of certain supplements or medications, or alternatively, the temporary avoidance of certain supplements or medications.
Do not stop or alter any medications without speaking to a licensed healthcare provider.
Zearalenone is a mycotoxin, a xenobiotic and an endocrine-disrupting chemical, with no known benefit to human or animal health. Therefore, optimal levels are undetectable.
One laboratory reports the following optimal level of zearalenone as < 0.5 ppb, and equivocal levels as 0.5-0.7 ppb. Zearalenone is present at levels of 0.7 ppb or more [10.].
Elevated zearalenone testing indicates the presence of zearalenone in the body, which can cause hormone imbalance, reproductive and metabolic disturbances, and increase an individual’s risk of cancer.
The presence of elevated zearalenone in an individual should prompt further assessment for the presence of additional mycotoxins, as well as other environmental toxins such as glyphosate.
Mycotoxins, produced by molds, can cause acute and chronic symptoms across multiple body systems [11.]. Similarly, glyphosate, a widely used herbicide, has been detected in human urine, with higher levels found in chronically ill individuals, in children, and in people consuming a diet high in cereals [8.].
Once discovered, a comprehensive detoxification protocol should be considered under the guidance of a licensed healthcare professional. A protocol should take into consideration an individual’s test results, symptoms, nutrition status, lifestyle, and other essential factors.
Always consult a licensed healthcare professional prior to beginning any new supplement, detoxification, or other protocols.
Click here to compare testing options and order tests for mycotoxins such as zearalenone.
[1.] Agag, B.I. (2004). MYCOTOXINS IN FOODS AND FEEDS 3-ZEARALENONE. Published 2004. Agricultural and Food Sciences, Environmental Science.
[2.] Jing S, Liu C, Zheng J, Dong Z, Guo N. Toxicity of zearalenone and its nutritional intervention by natural products. Food Funct. 2022 Oct 17;13(20):10374-10400. doi: 10.1039/d2fo01545e. PMID: 36165278.
[3.] Kowalska K, Habrowska-Górczyńska DE, Piastowska-Ciesielska AW. Zearalenone as an endocrine disruptor in humans. Environmental Toxicology and Pharmacology. 2016;48:141-149. doi:https://doi.org/10.1016/j.etap.2016.10.015
[4.] Kwaśniewska K, Gadzała-Kopciuch R, Cendrowski K. Analytical procedure for the determination of zearalenone in environmental and biological samples. Crit Rev Anal Chem. 2015;45(2):119-30. doi: 10.1080/10408347.2014.896731. PMID: 25558774.
[5.] Liu MT, Ram BP, Hart LP, Pestka JJ. Indirect enzyme-linked immunosorbent assay for the mycotoxin zearalenone. Applied and Environmental Microbiology. 1985;50(2):332-336. doi:https://doi.org/10.1128/aem.50.2.332-336.1985
[6.] Maqbool F, Mostafalou S, Bahadar H, Abdollahi M. Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms. Life Sci. 2016 Jan 15;145:265-73. doi: 10.1016/j.lfs.2015.10.022. Epub 2015 Oct 21. PMID: 26497928.
[7.] Metzler M, Pfeiffer E, Hildebrand A. Zearalenone and its metabolites as endocrine disrupting chemicals. World Mycotoxin Journal. 2010;3(4):385-401. doi:https://doi.org/10.3920/wmj2010.1244
[8.] Ospina M, Schütze A, Morales-Agudelo P, Vidal M, Wong LY, Calafat AM. Exposure to glyphosate in the United States: Data from the 2013-2014 National Health and Nutrition Examination Survey. Environ Int. 2022 Dec;170:107620. doi: 10.1016/j.envint.2022.107620. Epub 2022 Nov 4. PMID: 36368224; PMCID: PMC10240384.
[9.] Rogowska A, Pomastowski P, Sagandykova G, Buszewski B. Zearalenone and its metabolites: Effect on human health, metabolism and neutralisation methods. Toxicon: Official Journal of the International Society on Toxinology. 2019;162:46-56. doi:https://doi.org/10.1016/j.toxicon.2019.03.004
[10.] Rupa Health. Sample P. Mycotoxin Panel Sample Report.pdf. Google Docs. Published 2019. Accessed August 5, 2024. https://drive.google.com/file/d/1hU_rh5hoDqJeMv7ocrEyedWbHS-mHCAt/view
[11.] Sullivan AP. Mycotoxin Illness: Recognition and Management from Functional Medicine Perspective. Physical Medicine and Rehabilitation Clinics of North America. 2022;33(3):647-663. doi:https://doi.org/10.1016/j.pmr.2022.04.006
[12.] Tabb MM, Blumberg B. New Modes of Action for Endocrine-Disrupting Chemicals. Molecular Endocrinology. 2006;20(3):475-482. doi:https://doi.org/10.1210/me.2004-0513
[13.] Thevis M, Fußhöller G, Schänzer W. Zeranol: doping offence or mycotoxin? A case-related study. Drug Testing and Analysis. 2011;3(11-12):777-783. doi:https://doi.org/10.1002/dta.352
[14.] Videmann B, Mazallon M, Tep J, Lecoeur S. Metabolism and transfer of the mycotoxin zearalenone in human intestinal Caco-2 cells. Food Chem Toxicol. 2008 Oct;46(10):3279-86. doi: 10.1016/j.fct.2008.07.011. Epub 2008 Jul 23. PMID: 18692541.
[15.] Wang T, Zhou T, Wu K, et al. A sensitive monoclonal antibody-based ELISA integrated with immunoaffinity column extraction for the detection of zearalenone in food and feed samples. The Analyst. 2024;149(2):442-450. doi:https://doi.org/10.1039/d3an01779f
[16.] Zhang GL, Feng YL, Song JL, Zhou XS. Zearalenone: A Mycotoxin With Different Toxic Effect in Domestic and Laboratory Animals’ Granulosa Cells. Frontiers in Genetics. 2018;9. doi:https://doi.org/10.3389/fgene.2018.00667
[17.] Zheng W, Feng N, Wang Y, Noll L, Xu S, Liu X, Lu N, Zou H, Gu J, Yuan Y, Liu X, Zhu G, Bian J, Bai J, Liu Z. Effects of zearalenone and its derivatives on the synthesis and secretion of mammalian sex steroid hormones: A review. Food Chem Toxicol. 2019 Apr;126:262-276. doi: 10.1016/j.fct.2019.02.031. Epub 2019 Feb 27. PMID: 30825585.
[18.] Zheng W, Wang B, Li X, Wang T, Zou H, Gu J, Yuan Y, Liu X, Bai J, Bian J, Liu Z. Zearalenone Promotes Cell Proliferation or Causes Cell Death? Toxins (Basel). 2018 May 2;10(5):184. doi: 10.3390/toxins10050184. PMID: 29724047; PMCID: PMC5983240.
[19.] Gromadzka K. Zearalenone and its metabolites: occurrence, detection, toxicity and guidelines. Published April 23, 2008. Accessed August 5, 2024. https://www.ingentaconnect.com/content/wagac/wmj/2008/00000001/00000002/art00012?crawler=true&mimetype=application/pdf